Nestl, for example, has launched 'Vital Pursuit' a line of high-protein, portion-controlled frozen meals specifically for this demographic
Clinical trials for semaglutide (Ozempic, Wegovy) used once-weekly injection with dose escalation every four weeks
Relatively modest weight loss (510%) has been shown to have a positive impact on a broad range of metabolic and CV risk factors in patients with overweight or obesity, regardless of their diabetes status [15, 16], but until relatively recently there was limited evidence to suggest a beneficial effect of such weight loss on hard CV outcomes [17]
Robertson AGN, Wiggins T, Robertson FP, Huppler L, Doleman B, Harrison EM, et al
Recommended to another friend as well
Months 4-6: Acceleration Phase (Weeks 13-24) This is the sweet spot